REQUEST A DEMO
Total
USD $0.00
Search more companies

M.P.A. Medicinskie Partnery OOO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: M.P.A. Medicinskie Partnery OOO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

M.P.A. Medicinskie Partnery OOO is based in Russia. The head office is in Moscow. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on October 22, 2002. From the latest financial highlights, M.P.A. Medicinskie Partnery OOO reported a net sales revenue increase of 20.93% in 2023. Its’ total assets recorded a growth of 13.42%. The enterprise’s net profit margin increased by 5.55% in 2023.

Headquarters
8 Marta, 1, 12, 4, Pom XXVIII, Kom 4
Moscow; Moscow; Postal Code: 127083

Contact Details: Purchase the M.P.A. Medicinskie Partnery OOO report to view the information.

Website: http://mpa-projekt.ru

Basic Information
Outstanding Shares:
Purchase the M.P.A. Medicinskie Partnery OOO report to view the information.
Registered Capital:
Purchase the M.P.A. Medicinskie Partnery OOO report to view the information.
Incorporation Date:
October 22, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Subsidiaries
M.P.A. Medicinskie Partnery - Service OOO
20%
Company Performance
Financial values in the chart are available after M.P.A. Medicinskie Partnery OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
20.93%
Total operating revenue
20.93%
Operating profit (EBIT)
17.38%
Net Profit (Loss) for the Period
83.59%
Total assets
13.42%
Total equity
148.35%
Operating Profit Margin (ROS)
-0.94%
Net Profit Margin
5.55%
Return on Equity (ROE)
-21.07%
Quick Ratio
-0.06%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?